Victory Capital Management Inc Eloxx Pharmaceuticals, Inc. Transaction History

Victory Capital Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	SELL	$0.4 - $0.72 $4,316 - $7,769	-10,791 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$0.62 - $1.61 $203 - $529	-329 Reduced 2.96%	10,791 $8,000
Q3 2021 Nov 02, 2021	SELL	$1.22 - $2.0 $1,511 - $2,478	-1,239 Reduced 10.03%	11,120 $18,000
Q2 2021 Aug 03, 2021	BUY	$1.35 - $3.36 $16,684 - $41,526	12,359 New	12,359 $25,000
Q2 2020 Aug 07, 2020	SELL	$1.56 - $3.65 $6,052 - $14,162	-3,880 Closed	0 $0

Q1 2020 May 04, 2020	SELL	$1.96 - $7.96 $172 - $700	-88 Reduced 2.22%	3,880 $8,000
Q4 2019 Feb 04, 2020	BUY	$3.19 - $7.56 $676 - $1,602	212 Added 5.64%	3,968 $15,000
Q3 2019 Nov 12, 2019	BUY	$4.37 - $9.91 $16,413 - $37,221	3,756 New	3,756 $17,000

Ticker ELOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,656,200
Market Cap $59.8M
Description
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.